The global shortage of vaccines and its excess in the United States has quietly resulted in a new kind of tourism in the US, said an official.
Rich people from various countries of the world have been travelling to the United States to get shots of the COVID-19 vaccines, do some shopping and then fly back to their home country after a short stay.
Known as "vaccine tourism," this concept represents the fastest-growing category of visitors to the SFO Medical Clinic, where the free Johnson & Johnson single-dose vaccine is administered, the San Francisco International Airport said Wednesday.
The international airport in California is the first US airport to have released such data on vaccine tourism.
At present, 80 percent of new vaccine appointments at SFO are coming from non-US citizens, and over 1,000 doses have already been administered to visitors from 58 countries around the world, the airport said.
Of these 1,000, only eight are from India. The top five countries on this vaccine tourism list are Taiwan, Mexico, Philippines, South Korea and Peru. The figures are low for India, mainly because of the travel restrictions from India as imposed by the US due to the surge of coronavirus.
This trend truly represents a win-win situation for all," said Airport Director Ivar C Satero.
"It ensures that vaccine doses do not go unused by making them available to those who may have trouble accessing it in their home country. It also stimulates travel and visitor spending for the Bay Area, and most importantly it helps protect against community spread of the virus. My thanks go out to the entire team for making this program a reality," Satero said.
Since late May, the SFO Medical Clinic, located pre-security in the International Terminal, has been offering free single-dose Johnson & Johnson vaccines on an appointment basis.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU